Chenfang Dong

Key Laboratory Of Cancer Prevention And Intervention
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Lactylation of Mutation-Prone RAS Residues Mimics Oncogenic Mutations and Drives Constitutive Activation.

Lactylation of Mutation-Prone RAS Residues Mimics Oncogenic Mutations and Drives Constitutive Activation.

Journal: Cancer communications (London, England)

Published: January 04, 2026

ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression.

ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression.

Journal: Cell discovery

Published: July 24, 2025

RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization.

RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization.

Journal: Molecular cancer

Published: June 02, 2025

AKT1 glutarylation regulated by GCDH and SIRT5 suppresses oncogenic signaling.

AKT1 glutarylation regulated by GCDH and SIRT5 suppresses oncogenic signaling.

Journal: Cell reports

Published: April 25, 2025

Acetylation suppresses breast cancer progression by sustaining CLYBL stability.

Acetylation suppresses breast cancer progression by sustaining CLYBL stability.

Journal: Journal of translational medicine

Published: November 06, 2024

Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression.

Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression.

Journal: Cell communication and signaling : CCS

Published: November 26, 2023

AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.

AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.

Journal: Breast cancer research : BCR

Published: November 23, 2023

IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.

IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.

Journal: Cancer letters

Published: August 29, 2023

STNM1 in human cancers: role, function and potential therapy sensitizer.

STNM1 in human cancers: role, function and potential therapy sensitizer.

Journal: Cellular signalling

Published: April 19, 2023

Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy.

Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy.

Journal: Journal of medical virology

Published: December 06, 2022

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 18, 2022

HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.

HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.

Journal: Frontiers in oncology

Published: September 20, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026